Canada Opens Public Consultation on Potassium Bicarbonate Reevaluation Until September 8
On June 10, 2025, Health Canada released consultation document PRVD2025-06, initiating a reevaluation of potassium bicarbonate and its end-use products by the Pest Management Regulatory Agency (PMRA).
Potassium bicarbonate is widely registered for controlling powdery mildew on greenhouse and field crops, including ornamentals, vegetables, fruits, herbs, and spices. It is also approved for managing gray mold on grapes and partially mitigating apple scab in orchards. Additionally, it is used on cannabis and industrial hemp, both in greenhouse settings and open fields.
The public consultation period runs from June 10, 2025, to September 8, 2025, allowing stakeholders to submit feedback on the pesticide’s usage and safety.
2026-10-18
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
TSMC, Samsung, and SK Hynix Scramble for Electronic-Grade Hydrofluoric Acid as High-End Supply Tightens; Some Suppliers Raise Prices by 30% This Year
-
“Amputation or Strategic Retreat?”: Shell’s Six-Year Chemical Losses and the Quiet Unwinding of an Empire
-
Tinci Materials Calls Off 2.65 Billion Yuan Project as Electrolyte Giant Shifts Strategy
-
“The 40-Year Ethylene Giant Collapses”: ExxonMobil’s Premature Shutdown Is Not Just Scotland’s Tragedy—It’s the Twilight Elegy of European Industrial Civilization
-
Eastern Shenghong Projects First-Half Profit of 5 Billion Yuan – A Collective Turnaround for the Four Major Private Refiners? Is the Chemical Sector Rebounding?
-
U.S.-Iran Détente Triggers Oil Price Plunge, Energy and Chemical Sectors Tumble
-
Sulfur Price Hits 7,633 CNY/Ton, Up Nearly Sixfold in a Year and a Half; Domestic Refining Giants Halt New Orders Due to Tight Supply
-
Indian Immunologicals Pushes Back on “Fake Vaccine” Claims Amid Global Supply Chain Scrutiny
-
Obesity Drugs Become Pharma’s Most Powerful Growth Engine
-
Substandard Drug Findings Expose Deep Structural Gaps in Medicine Quality Control
Recommend Reading
-
Selling the Family Silver for a New Suit? Why Bohai Chemical’s Transformation Drama Got Canceled After Just Two Acts
-
MDI Price Surge Hits EMEAI: Is This a Market Correction or the Beginning of a Supply Crisis?
-
“Deregulation” or “Concession”? The Hidden Crisis Behind India’s Repeal of QCOs on Seven Key Petrochemicals
-
From Painting Walls to Total Collapse: The RMB 152 Million Debt That Tore Off the Last Veil of Asia Chuangneng’s Paint Empire
-
Cracking Europe: When the Chemical Empire Loses Its Heat
-
High Costs and Supply Contraction Keep Dichloromethane Prices Relatively Strong
-
Mainstay Enterprises Reduce Load, PC Prices Rise in Early December in China
-
This Week's Pure Benzene Market Prices Show Slight Fluctuations (2.2-2.6)
-
Acetic Acid Prices Continue to Rise in Early December
-
Phosphoric Acid Market Prices Slightly Up (2.1–2.6)